MedTrace Logo

Impact of CMV Status on HIV Viral Load Decay

NCT03349359 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 345

Last updated 2017-11-21

No results posted yet for this study

Summary

Background: Cytomegalovirus (CMV) infection is usually observed among patients with HIV infection. No study to date has investigated the impact of CMV infection on HIV viral load decay during antiretroviral therapy.

Methods: 345 consecutive HIV patients coinfected (N=300) or not (N=45) with CMV were enrolled. Clinical, biological and virological data were collected from HIV antiretroviral therapy initiation to the day of HIV viral load undetectability if any.

Conditions

Interventions

DRUG

HIV antiretroviral therapy

HIV patients are receiving an antiretroviral therapy according to the physician's discretion and the availability of drugs

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-01
Primary Completion
2017-01-30
Completion
2017-01-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03349359 on ClinicalTrials.gov